Associated Papers
Association between the oxidative stress gene polymorphism and chronic obstructive pulmonary disease risk: a meta-analysis.
Zhou T et al.
Bmc Pulmonary Medicine, 2023
Genetic polymorphisms and lung cancer risk: Evidence from meta-analyses and genome-wide association studies.
Liu C et al.
Lung Cancer (amsterdam, Netherlands), 2017
EPHX1 Y113H polymorphism is associated with increased risk of chronic obstructive pulmonary disease in Kazakhstan population.
Akparova A et al.
Mutation Research. Genetic Toxicology and Environmental Mutagenesis, 2017
Role and diagnostic value of gene variants in assessing the risk of chronic obstructive pulmonary disease.
Yan ZP et al.
Genetics and Molecular Research : Gmr, 2016
The programmed cell death 6 interacting protein insertion/deletion polymorphism is associated with non-small cell lung cancer risk in a Chinese Han population.
Liu SG et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2014
Relationships between CYP1A1 genetic polymorphisms and bladder cancer risk: a meta-analysis.
Wang Y et al.
Dna and Cell Biology, 2014
The programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with non-small cell lung cancer risk in a Chinese Han population.
Yin L et al.
International Journal of Clinical and Experimental Medicine, 2014
Association between microsomal epoxide hydrolase 1 T113C polymorphism and susceptibility to lung cancer.
Wang S et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2013
Microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease: A comprehensive meta-analysis.
Li H et al.
Oncology Letters, 2013
EPHX1 A139G polymorphism and lung cancer risk: a meta-analysis.
Liu H et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine, 2013
Genetically lowered microsomal epoxide hydrolase activity and tobacco-related cancer in 47,000 individuals.
Lee J et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2011
EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis.
Lee J et al.
The European Respiratory Journal, 2011
CYP1A1, mEH, and GSTM1 Polymophisms and Risk of Oral and Pharyngeal Cancer: A Spanish Case-Control Study.
Varela-Lema L et al.
Journal of Oncology, 2008
[Relation Between microsomal epoxide hydrolase polymorphism and susceptibility to ovarian epithelial cancer].
Kang S et al.
Zhonghua Fu Chan Ke Za Zhi, 2004
[Association between polymorphisms in the microsomal epoxide hydrolase (mEH) gene and chronic obstructive pulmonary disease].
Xiao D et al.
Zhonghua Yi Xue Za Zhi, 2003
Epoxide hydrolase genotype and orolaryngeal cancer risk: interaction with GSTM1 genotype.
Park JY et al.
Oral Oncology, 2003